Literature DB >> 24200867

Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.

Erica Zamberletti1, Sarah Beggiato2, Luca Steardo3, Pamela Prini1, Tiziana Antonelli2, Luca Ferraro4, Tiziana Rubino1, Daniela Parolaro5.   

Abstract

Although several findings indicate an association between adolescent cannabis abuse and the risk to develop schizophrenia later in life, the evidence for a causal relationship is still inconclusive. In the present study, we investigated the emergence of psychotic-like behavior in adult female rats chronically exposed to delta-9-tetrahydrocannabinol (THC) during adolescence. To this aim, female Sprague-Dawley rats were treated with THC during adolescence (PND 35-45) and, in adulthood (PND 75), a series of behavioral tests and biochemical assays were performed in order to investigate the long-term effects of adolescent THC exposure. Adolescent THC pretreatment leads to long-term behavioral alterations, characterized by recognition memory deficits, social withdrawal, altered emotional reactivity and sensitization to the locomotor activating effects of acute PCP. Moreover, since cortical disinhibition seems to be a key feature of many different animal models of schizophrenia and GABAergic hypofunction in the prefrontal cortex (PFC) has been observed in postmortem brains from schizophrenic patients, we then investigated the long-lasting consequences of adolescent THC exposure on GABAergic transmission in the adult rat PFC. Biochemical analyses revealed that adolescent THC exposure results in reduced GAD67 and basal GABA levels within the adult PFC. GAD67 expression is reduced both in parvalbumin (PV)- and cholecystokinin (CCK)-containing interneurons; this alteration may be related to the altered emotional reactivity triggered by adolescent THC, as silencing PFC GAD67 expression through a siRNA-mediated approach is sufficient to impact rats' behavior in the forced swim test. Finally, the cellular underpinnings of the observed sensitized response to acute PCP in adult THC-treated rats could be ascribed to the increased cFos immunoreactivity and glutamate levels in the PFC and dorsal striatum. The present findings support the hypothesis that adolescent THC exposure may represent a risk factor for the development of a complex psychotic-like behavior in adulthood.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent THC treatment; Behavior; GABA; GAD67; Glutamate; Prefrontal cortex

Mesh:

Substances:

Year:  2013        PMID: 24200867     DOI: 10.1016/j.nbd.2013.10.028

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  48 in total

Review 1.  Neural substrates underlying the negative impact of cannabinoid exposure during adolescence.

Authors:  Hanna M Molla; Kuei Y Tseng
Journal:  Pharmacol Biochem Behav       Date:  2020-06-09       Impact factor: 3.533

2.  l-Theanine Prevents Long-Term Affective and Cognitive Side Effects of Adolescent Δ-9-Tetrahydrocannabinol Exposure and Blocks Associated Molecular and Neuronal Abnormalities in the Mesocorticolimbic Circuitry.

Authors:  Marta De Felice; Justine Renard; Roger Hudson; Hanna J Szkudlarek; Brian J Pereira; Susanne Schmid; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

3.  Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.

Authors:  Yan Jouroukhin; Xiaolei Zhu; Alexey V Shevelkin; Yuto Hasegawa; Bagrat Abazyan; Atsushi Saito; Jonathan Pevsner; Atsushi Kamiya; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2018-08-16       Impact factor: 13.382

Review 4.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

5.  An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity.

Authors:  Jonathan W Lovelace; Alex Corches; Philip A Vieira; Alex S Hiroto; Ken Mackie; Edward Korzus
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

6.  Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?

Authors:  Matthew N Hill
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

Review 7.  Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.

Authors:  Felipe V Gomes; Millie Rincón-Cortés; Anthony A Grace
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

Review 8.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

Review 9.  Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Authors:  Leigh V Panlilio; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-08-28       Impact factor: 7.853

Review 10.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.